Uploaded September 2026 | Updated November 2026, 3 days ago
Even taking the trial at face value, it does not match what people buy. It was an enema, in ulcerative colitis patients, at 80 mg a day for two weeks. The companies wanted to sell capsules, injections, nasal sprays, creams, and suppositories. The FDA went looking for human studies of BPC-157 by any of those routes and found nothing. The closest match, a suppository, still does not match, because an enema reaches much further up the colon.
Even taking the trial at face value, it does not match what people buy. It was an enema, in ulcerative colitis patients, at 80 mg a day for two weeks. The companies wanted to sell capsules, injections, nasal sprays, creams, and suppositories. The FDA went looking for human studies of BPC-157 by any of those routes and found nothing. The closest match, a suppository, still does not match, because an enema reaches much further up the colon.










